| Dr David S Gorelick, MD | |
|
50 Memorial Blvd, Aquidneck Medical Associates, Inc, Newport, RI 02840-3587 | |
| (401) 847-2290 | |
| (401) 849-8446 |
| Full Name | Dr David S Gorelick |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 50 Memorial Blvd, Newport, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841297322 | NPI | - | NPPES |
| 9020235 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD08471 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newport Hospital | Newport, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifespan Physician Group Inc | 2567455082 | 631 |
News Archive
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
Now that lawmakers have an extension on pressing budget issues, they are refocusing attention on the health law's "rocky rollout." For instance, GOP leaders are pressing administration officials for answers about what's gone wrong with the federal online health insurance marketplace.
Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.
A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.
› Verified 3 days ago
| Entity Name | Newport Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265652358 PECOS PAC ID: 0042111437 Enrollment ID: O20040412000606 |
News Archive
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
Now that lawmakers have an extension on pressing budget issues, they are refocusing attention on the health law's "rocky rollout." For instance, GOP leaders are pressing administration officials for answers about what's gone wrong with the federal online health insurance marketplace.
Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.
A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.
› Verified 3 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
Now that lawmakers have an extension on pressing budget issues, they are refocusing attention on the health law's "rocky rollout." For instance, GOP leaders are pressing administration officials for answers about what's gone wrong with the federal online health insurance marketplace.
Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.
A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David S Gorelick, MD 50 Memorial Blvd, Aquidneck Medical Associates, Inc, Newport, RI 02840-3587 Ph: (401) 847-2290 | Dr David S Gorelick, MD 50 Memorial Blvd, Aquidneck Medical Associates, Inc, Newport, RI 02840-3587 Ph: (401) 847-2290 |
News Archive
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
Now that lawmakers have an extension on pressing budget issues, they are refocusing attention on the health law's "rocky rollout." For instance, GOP leaders are pressing administration officials for answers about what's gone wrong with the federal online health insurance marketplace.
Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.
A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.
› Verified 3 days ago
Daniela Mccooey, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-1281 | |
Dr. John Thomas Mccaffrey, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 409 Broadway, Newport, RI 02840 Phone: 401-849-1280 Fax: 401-847-2815 | |
Brandon Forrest Boldt, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 293 Kollmeyer St, Newport, RI 02841 Phone: 401-841-7987 | |
Dr. Ralph Thomas Earp, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 Memorial Blvd, Aquidneck Medical Associates, Newport, RI 02840 Phone: 401-847-2290 Fax: 401-849-8446 | |
Dr. Danielle Saldin, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-845-4265 | |
Irina Chernaya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Friendship St, Newport, RI 02840 Phone: 401-846-6400 | |
Alessandro Papa, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 Friendship St, Suite 360, Newport, RI 02840 Phone: 401-845-1998 Fax: 401-848-6510 |